CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tissue Regenix Group PLC Company Snapshot
Tissue Regenix Group plc is a United Kingdom-based medical devices company. The Company is principally engaged in the exploitation of platform technologies in the field of tissue engineering and regenerative medicine. The Company has developed decellularisation (dCELL) technology, which removes DNA and other cellular material from tissue leaving an acellular scaffold which is not rejected by the patient's body. The applications of dCELL address critical clinical needs, such as wound care, vascular disease, heart valve replacement and knee repair. The Company has developed DermaPure, a human dermis product. The Company offers OrthoPure category products, including porcine meniscus products used to repair damage from tears in the meniscus knee cartilage and tendon products used for surgical reconstruction of a torn anterior cruciate ligament in the knee. In addition, the company offers CardioPure HV, a human heart valve product.

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tissue Regenix Group PLC
  Stock Performance Chart for Tissue Regenix Group PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (5/27/2016): 20.25p
(Figures in Pounds Sterling)
1 Week 12.5%   13 Weeks 2.5%  
4 Weeks 26.6%   52 Weeks 0.6%  
 
Tissue Regenix Group PLC Key Data:
  Ticker: TRX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 816,000
(Year Ending Jan 2017).
Employees: 70
  Currency: Pounds Sterling Market Cap: 153,925,163
  Fiscal Yr Ends: January Shares Outstanding: 760,124,264
  Share Type: Ordinary Closely Held Shares: 229,190,157
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.